The CHMP has recommended granting a marketing authorisation for Unituxin (dinutuximab) from United Therapeutics for the treatment of high-risk neuroblastoma,...
United Therapeutics Corporation announced that the European Commission (EC) has granted Marketing Authorisation for Unituxin (dinutuximab) for the treatment of...
The National Institute for Health and Care Excellence (NICE) in draft guidelines has recommended that Unituxin (dinutuximab) from United Therapeutics...
The FDA has approved Unituxin (dinutuximab) Injection, from United Therapeutics Corp, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2),...